SCHEMBL5035778

SCHEMBL5035778

COc1ccc(N(C(=O)c2ccc(Cl)cc2Cl)c2nc(C(=O)O)cs2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
MAPT P10636 1/20 0.46
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
LDHA P00338 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PTGER1 P34995 2/20 0.39
MARS1 P56192 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KCNH2 Q12809 1/20 0.39
LTC4S Q16873 1/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GRIK1 P39086 1/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034952 0.90 CYP3A4 (0.46) RAB9ACYP3A4LDHAMEN1KMT2A
SCHEMBL5041155 0.90 CYP3A4 (0.39) RAB9AMAPTCYP3A4MEN1KMT2A
SCHEMBL5032527 0.90 ALDH1A1 (0.46) RAB9AMAPTCYP3A4FLT1FLT4
SCHEMBL6491939 0.89 MAPT (0.40) RAB9AMAPTLMNALDHAMEN1
SCHEMBL5032520 0.88 LMNA (0.47) RAB9AMAPTLMNALDHAMEN1
SCHEMBL5035123 0.87 DHODH (0.42) CYP3A4LDHAMARS1LTC4SKDM4E
SCHEMBL5035149 0.85 ALDH1A1 (0.41) RAB9AMAPTCYP3A4FLT1FLT4
SCHEMBL5036201 0.85 CYP3A4 (0.42) RAB9AMAPTLMNACYP3A4GAA
SCHEMBL6491942 0.83 TSHR (0.42) MEN1KMT2AMARS1NPSR1NPC1
SCHEMBL5034786 0.82 CYP3A4 (0.44) RAB9AMAPTCYP3A4FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP disclosed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 RAB9A 1847/4885MAPT 3183/4885LMNA 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.